Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zepp HealthFRA:ST0 -1.32%45 Return-on-Tangible-Asset is -15.04% as of Mar. 2026. GuruFocus rates FRA:ST0 with a GF Score™ of 45/100 and a GF Value™ of €3.29 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 2,503 Hardware companies, Zepp Health ranks worse than 83.18% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Zepp Health's annualizedNet Income for the quarter that ended in Mar. 2026 was €-68.0 Mil. Zepp Health's average total tangible assets for the quarter that ended in Mar. 2026 was €451.8 Mil. Therefore, Zepp Health's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -15.04%.
The historical rank and industry rank for Zepp Health's Return-on-Tangible-Asset or its related term are showing as below:
FRA:ST0'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -13.43 Med: 2.77 Max: 14.41
Current: -7.59
During the past 11 years, Zepp Health's highest Return-on-Tangible-Asset was 14.41%. The lowest was -13.43%. And the median was 2.77%.
FRA:ST0's Return-on-Tangible-Asset is ranked worse than 83.18% of 2503
companies
in the Hardware industry
Industry Median: 2.44
vs FRA:ST0: -7.59
Zepp Health (FRA:ST0) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Zepp Health Return-on-Tangible-Asset Related Terms
Zepp Health Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Zepp Health's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ST0 vs UEIC, AXIL, KOSS: Return-on-Tangible-Asset Comparison
For the Consumer Electronics subindustry, Zepp Health's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zepp Health Return-on-Tangible-Asset vs Hardware Industry
For the Hardware industry and Technology sector, Zepp Health's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Zepp Health's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -15.04% mean?
Zepp Health (FRA:ST0) has a Return-on-Tangible-Asset of -15.04% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #2082 out of 2503 companies in the Hardware industry, placing it in the top 83.2%.
Is Zepp Health's Return-on-Tangible-Asset too high?
Zepp Health's current Return-on-Tangible-Asset is -15.04%. Based on the distribution chart, Zepp Health ranks #2082 out of 2503 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Zepp Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's Return-on-Tangible-Asset compare to UEIC and AXIL?
According to the Hardware industry distribution chart, Zepp Health ranks #2082 out of 2503 companies for Return-on-Tangible-Asset. This places Zepp Health in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Hardware company?
The median Return-on-Tangible-Asset among Hardware companies is 2.44, based on 2,503 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Zepp Health and its competitors. For the Hardware industry, the median Return-on-Tangible-Asset is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zepp Health's current Return-on-Tangible-Asset is -15.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.29, compared to a current price of €4.48 — trading 36.2% above its estimated fair value. The current Return-on-Tangible-Asset is -15.04%. Zepp Health's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current Return-on-Tangible-Asset is -15.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zepp Health (FRA:ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued.
The current stock price of €4.48 is trading 36.2% above its estimated GF Value™ of €3.29.
GuruFocus considers Zepp Health to be Significantly Overvalued.
Key valuation signals for FRA:ST0:
Return-on-Tangible-Asset: -15.04%
GF Value™: €3.29 vs. price of €4.48 (36.2% above fair value)
No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
45GF Score
Get the complete analysis for FRA:ST0
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ST0 has been successfully added to your 
